Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics...
37 insider purchases on record · latest filing 2025-10-03.
Insiders have also filed 11 sale transactions at SNGX.